Higher median levels of free β-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group

被引:45
作者
Leung, TY
Spencer, K
Leung, TN
Fung, TY
Lau, TK [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China
[2] Harold Wood Hosp, Dept Clin Biochem, Romford, Essex, England
关键词
biochemical markers; Chinese; first trimester; screening; trisomy; 21;
D O I
10.1159/000089064
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To study the effect of ethnic Chinese on the medians of free beta-hCG and PAPP-A in the first trimester of pregnancy. Methods: The data of 943 women undergoing first trimester combined screening for fetal Down syndrome were analysed to derive the Chinese-specific medians. The calculated risk of Down syndrome based on these Chinese-specific medians was compared with that based on the original algorithm of the Fetal Medicine Foundation (FMF). Results: The maternal serum levels of multiples of median of free beta-hCG and PAPP-A were significantly higher among the Chinese than among the Caucasians. The weight-adjusted gestation-specific medians were developed. Without adjustment for ethnicity, the original FMF algorithm underestimated the risk of Down syndrome by a median of 1%. Adjustment by ethnicity increased the false-positive rate by 10% (from 5.3 to 5.9%). Conclusion: Ethnic Chinese have a significantly higher maternal serum level of free beta-hCG and PAPP-A in the first trimester, which could not be explained by differences in maternal weight. Adjustment for ethnicity may be necessary for these biochemical markers in a first trimester screening program. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:140 / 143
页数:4
相关论文
共 15 条
[1]  
Benn PA, 1997, CLIN CHEM, V43, P333
[2]   LOW MATERNAL SERUM LEVELS OF PREGNANCY ASSOCIATED PLASMA PROTEIN-A (PAPP-A) IN THE 1ST TRIMESTER IN ASSOCIATION WITH ABNORMAL FETAL KARYOTYPE [J].
BRAMBATI, B ;
MACINTOSH, MCM ;
TEISNER, B ;
MAGUINESS, S ;
SHRIMANKER, K ;
LANZANI, A ;
BONACCHI, I ;
TULUI, L ;
CHARD, T ;
GRUDZINSKAS, JG .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1993, 100 (04) :324-326
[3]   Variability of adjustments to indices in determining patient risk in biochemical screening [J].
Brooks, K ;
Chik, L ;
O'Brien, JE ;
Ayoub, M ;
Johnson, MP ;
Evans, MI .
FETAL DIAGNOSIS AND THERAPY, 1999, 14 (01) :41-46
[4]   Maternal weight differences do not explain ethnic differences in biochemical screening [J].
Bryant-Greenwood, PK ;
O'Brien, JE ;
Huang, XH ;
Yaron, Y ;
Ayoub, M ;
Johnson, MP ;
Evans, MI .
FETAL DIAGNOSIS AND THERAPY, 1998, 13 (01) :46-48
[5]  
HSIEH TT, 1995, AM J HUM GENET, V57, P1632
[6]  
Neveux LM, 1996, PRENATAL DIAG, V16, P1115, DOI 10.1002/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO
[7]  
2-6
[8]   Race-ethnicity-specific variation in multiple-marker biochemical screening: Alpha-fetoprotein, hCG, and estriol [J].
OBrien, JE ;
Dvorin, E ;
Drugan, A ;
Johnson, MP ;
Yaron, Y ;
Evans, MI .
OBSTETRICS AND GYNECOLOGY, 1997, 89 (03) :355-358
[9]   UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation [J].
Snijders, RJM ;
Noble, P ;
Sebire, N ;
Souka, A ;
Nicolaides, KH .
LANCET, 1998, 352 (9125) :343-346
[10]   Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience [J].
Spencer, K ;
Spencer, CE ;
Power, M ;
Dawson, C ;
Nicolaides, KH .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2003, 110 (03) :281-286